Millendo drops another drug candidate

ANN ARBOR—Millendo Therapeutics Inc. (Nasdaq: MLND), a pharmaceutical startup developing new drugs for endocrine diseases, announced that it had engaged SVB Leerink, a Boston-based investment bank, in a “strategic review …

Millendo awards stock options

ANN ARBOR –Millendo Therapeutics Inc. (Nasdaq: MLND), the Ann Arbor pharmaceutical company developing  treatments for endocrine diseases, announced the grant of inducement stock options to three new employees of the …